SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
tmw
Lv5
830 积分
2023-01-14 加入
最近求助
最近应助
互助留言
Sunvozertinib: First Approval
3天前
已完结
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
4天前
已完结
507O EXCLAIM-2: Phase III trial of first-line (1L) mobocertinib versus platinum-based chemotherapy in patients (pts) with epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)+ locally advanced/metastatic NSCLC
4天前
已完结
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer
4天前
已完结
7P Patient-relevant endpoints from PAPILLON: Amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated (Ex20ins) advanced NSCLC
4天前
已完结
Abstract CT102: Interim results of a first-in-human, dose escalation and expansion study of PLB-1004, an irreversible inhibitor of exon 20 insertion mutations in patients with non-small cell lung cancer
4天前
求助中
988P Phase I/II study of mobocertinib in EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): Updated results from platinum-pretreated patients (PPP)
4天前
已完结
1325P Sunvozertinib as first-line treatment in NSCLC patients with EGFR Exon20 insertion mutations
4天前
已完结
Structural Mechanism and Inhibitors Targeting EGFR Exon 20 Insertion (Ex20ins) Mutations
5天前
已完结
Amivantamab: First Approval
5天前
已完结
没有进行任何应助
感谢,点赞
2个月前
感谢,点赞
2个月前
感谢,点赞
2个月前
感谢,点赞
3个月前
不是这个,这个是白血病的文章,我要的是肺癌相关的文章
4个月前
感谢,点赞
4个月前
感谢,点赞
6个月前
感谢,点赞
6个月前
感谢,点赞
7个月前
感谢,点赞
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论